PICS-CSI-Asia

PICS-CSI Asia will give a comprehensive overview of major topics in catheter therapy of congenital, structural and valvar heart disease and is designed for adult and pediatric interventional cardiologists, cardiothoracic surgeons, anesthesiologists, imaging specialists, nurses, technicians and any other medical specialty involved in these procedures. It will also provide opportunities for engineers, device design specialists and inventors to learn from and network with physicians. 

Catheter Interventions in Congenital, Structural and Valvular Heart Disease (CSI)

CSI (Catheter Interventions in Congenital, Structural and Valvular Heart Disease) 2016 in Frankfurt offers the unique experience of a comprehensive overview of major topics in the catheter therapy of congenital, structural and valvular heart disease in children and adults. CSI caters for adult and pediatric interventional cardiologists, cardiothoracic surgeons, anesthesiologists and imaging specialists.

With the world’s elderly population expected to double by 2050, understanding how aging affects the body is an important focus for researchers globally. Cardiovascular disease, the No. 1 cause of death worldwide, often is associated with aging arteries that restrict blood flow. Now, University of Missouri researchers have identified an age-related cause of arterial dysfunction, a finding that could lead to future treatments for some forms of vascular disease.

genomic testing, NGS, FDA, Precision Medicine Initiative, PMI, workshops

The U.S. Food and Drug Administration (FDA) will hold a pair of public workshops in November to explain ongoing efforts to develop regulations and standards for next-generation sequencing (NGS)-based clinical tests. The focus on NGS tests is part of President Obama’s Precision Medicine Initiative (PMI) to help customize healthcare for individuals based on genetic makeup.

University of Texas Southwestern cardiologist Benjamin Levine, M.D., will use NASA-honed technology to monitor swimmer Ben Lecomte in his record-setting goal to become the first person to swim across the Pacific Ocean. Lecomte will  plunge into the ocean off of a Tokyo beach this summer heading for San Francisco.

Zoll Medical Corp. announced that it has acquired Tel Aviv, Israel-based Kyma Medical Technologies Ltd., which develops technologies to measure early signs of congestive heart failure.

Medical Design & Manufacturing (MD&M)

Minnesota Medtech Week is an unprecedented combination of the two most important medical device and health technology events in the region, which have a combined 50-year history in the Twin Cities. The event will gather all key players in the industry – from engineers and product developers to physicians, hospital administrators and executives. Concurrent conference tracks take deep dives into two of the most important industry topics—market access and patient engagement.

Cook Medical has received premarket approval from the U.S. Food and Drug Administration (FDA) for its lower-profile Zenith Alpha Thoracic endovascular graft.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now